Taken together from the aforementioned discussion it can be postulated that CME reduced HFD induced dyslipidemia and increased body weight gain through different pathways such as up-regulation of leptin, UCP1 and adiponectin expression and antioxidant activity. This evidence concerns the gene LEP and metabolic syndrome.